Skip to content
Clinical Trial Events
DIA Europe

Roundtable Value & Access track

S1004 - Workshop on HTA Advice: JSC or National Advice?

Thu, Mar 20, 2025 · 8:30–9:40 AM CET Sydney Room, Congress Center Basel

About this session

This interactive Think Tank will seek to answer the question of JSC or national advice in a multistakeholder environment. The session will start with introductory presentation of different advice procedures in EU and NICE, followed by roundtable discussions and summarised by explaining the role of Scientific Advice and expectations for the Regulatory Auhorities, HTA bodies and HTDs.

Programme:
- Table 3: National HTA advice and industry best practices — Thomas Ecker
- Table 2: Generating evidence that makes difference (RCT and beyond) — Anja Schiel
- Table 1: Navigating the new Joint Scientific Consultation system — Sonia Pulido Sanchez
- 1. Different Advice Procedures in Europe — Claudine Sapede, Inka Heikkinen

Speakers

  • Thomas Ecker

    Independent JCA Expert

    Speaker

  • Anja Schiel

    Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA · Norwegian Medicines Agency (NoMA)

    Speaker

  • Inka Heikkinen

    Regulatory Policy Lead, Director · Lundbeck

    Chair

  • Sonia Pulido Sanchez

    HTA Project Manager and JSC SG Co-Chair · AEMPS

    Speaker

  • Claudine Sapede

    Director, Global HTA Policy · NOVARTIS INTERNATIONAL

    Speaker

  • Matias Olsen

    Associate Director, Public Affairs & Policy · EUCOPE

    Chair